Longpre Lara has filed 6 insider transactions across 1 company since September 2019.
Most recent transaction: a purchase of 965 shares of Mirum Pharmaceuticals, Inc. ($MIRM) on September 10, 2019.
Activity breakdown: 1 open-market purchase and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 10, 2019 | Mirum Pharmaceuticals, Inc. | $MIRM | Longpre Lara | CHIEF DEVELOPMENT OFFICER | P | Common Stock | 965 | $10.64 | 105,372.0000 | 0 | 0.92% | 0.00% |
| Jan. 9, 2023 | Mirum Pharmaceuticals, Inc. | $MIRM | Longpre Lara | CHIEF DEVELOPMENT OFFICER | S | Common Stock | 1003 | $20.62 | 104,369.0000 | 33,982,493 | 0.95% | 0.00% |
| Feb. 2, 2024 | Mirum Pharmaceuticals, Inc. | $MIRM | Longpre Lara | CHIEF DEVELOPMENT OFFICER | S | Common Stock | 847 | $26.19 | 104,407.0000 | 40,885,124 | 0.80% | 0.00% |
| Jan. 23, 2024 | Mirum Pharmaceuticals, Inc. | $MIRM | Longpre Lara | CHIEF DEVELOPMENT OFFICER | A | Stock Option (right to buy) | 32000 | $0.00 | 32,000.0000 | 40,885,124 | 9999.99% | 0.08% |
| Jan. 23, 2024 | Mirum Pharmaceuticals, Inc. | $MIRM | Longpre Lara | CHIEF DEVELOPMENT OFFICER | A | Restricted Stock Units | 8000 | $0.00 | 8,000.0000 | 40,885,124 | 9999.99% | 0.02% |
| Jan. 8, 2024 | Mirum Pharmaceuticals, Inc. | $MIRM | Longpre Lara | CHIEF DEVELOPMENT OFFICER | S | Common Stock | 1019 | $28.04 | 105,254.0000 | 40,885,124 | 0.96% | 0.00% |